Display Settings:

Format

Send to:

Choose Destination
    PLoS Pathog. 2010 Oct 14;6(10):e1001033.

    Host genetics and HIV-1: the final phase?

    Source

    Center for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, United States of America. jacques.fellay@duke.edu

    Abstract

    This is a crucial transition time for human genetics in general, and for HIV host genetics in particular. After years of equivocal results from candidate gene analyses, several genome-wide association studies have been published that looked at plasma viral load or disease progression. Results from other studies that used various large-scale approaches (siRNA screens, transcriptome or proteome analysis, comparative genomics) have also shed new light on retroviral pathogenesis. However, most of the inter-individual variability in response to HIV-1 infection remains to be explained: genome resequencing and systems biology approaches are now required to progress toward a better understanding of the complex interactions between HIV-1 and its human host.

    PMID:
    20976252
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2954832
    Free PMC Article

    Images from this publication.See all images (4) Free text

    Figure 2
    Figure 4
    Figure 1
    Figure 3

      Supplemental Content

      Icon for Public Library of Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk